RxDoctor Payments Data

Trevor Page, DO

Family Medicine · Washington, UTNPI 1053603597

Payments from drug & device makers

$1,641in general payments, 2019–2025

Across 110 payments — averaging $14.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$872
  • AstraZeneca$122
  • Indivior Inc.$90
  • Abbott$56
  • Johnson & Johnson$53
  • Merck$52
  • plus $396 from 16 others

What the payments were for

  • Food & beverage$1,641100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,641 in reported general payments places this provider in the 65th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$1,606
Medicare patients
29
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$98,169
FarxigaDapagliflozin Propanediol40$56,100
XareltoRivaroxaban22$34,081
OzempicSemaglutide23$32,080
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$30,303
TrulicityDulaglutide20$26,460
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$23,322
JardianceEmpagliflozin12$20,855
JanuviaSitagliptin Phosphate12$19,304
LinzessLinaclotide20$13,828
MounjaroTirzepatide11$11,015
MyrbetriqMirabegron13$7,397
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$5,227
Atorvastatin Calcium231$2,027
Lidocaine19$1,628

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$28$98,16964 claims
AstraZenecaFarxiga$122$56,10040 claims
Lilly USA, LLCTrulicity, Mounjaro$30$37,47531 claims
Johnson & JohnsonXarelto$53$34,08122 claims
Novo NordiskOzempic$39$32,08023 claims
Boehringer IngelheimJardiance$18$20,85512 claims
MerckJanuvia$52$19,30412 claims
AbbVieLinzess$872$13,82820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 928 family medicine providers in Utah.

Other family medicine in Washington

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →